Jornal Brasileiro de Nefrologia is a distinguished open-access journal published by the Sociedade Brasileira de Nefrologia, catering to the dynamic field of nephrology. Since its inception, the journal has been a vital platform for disseminating cutting-edge research, clinical practices, and advancements in nephrology, particularly focusing on the Brazilian healthcare context. With an E-ISSN of 2175-8239, the journal has embraced open-access policies since 2009, promoting wider reach and accessibility for its readership. Operating out of São Paulo, Brazil, the journal holds a Q3 ranking in Nephrology as of 2023 and has contributed significantly to the academic landscape by showcasing innovative studies and discussions that shape nephrology practice. The journal not only serves as a resource for researchers but also supports nephrologists, clinicians, and students in their pursuit of knowledge, ensuring that critical developments in kidney health are shared widely. With annual publication cycles from 2010 to 2024, the Jornal Brasileiro de Nefrologia remains committed to advancing the discipline while engaging an international audience dedicated to improving patient care in nephrology.

Clinical and Experimental Nephrology, published by SPRINGER, serves as a crucial platform for researchers and practitioners in the field of nephrology. With its roots dating back to 1999, the journal has made significant strides in exploring various dimensions of kidney health, thereby enriching our understanding of nephrological diseases. Aimed at fostering interdisciplinary dialogue, it covers a broad spectrum of topics from clinical practices to experimental research, evidenced by its ranked quartiles of Q2 in Nephrology and Q3 in both Physiology and Medical Physiology within its latest evaluation. Although not open access, the journal's rigorous peer-review process ensures the publication of high-quality research, making it a valuable resource for professionals, academic institutions, and students. The journal is located in Japan, with its editorial office situated at One New York Plaza, Suite 4600, New York, NY 10004, United States, reflecting its global influence and intent to disseminate critical findings in nephrology and beyond.

Saudi Journal of Kidney Diseases and Transplantation, published by Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of nephrology and transplantation, dedicated to advancing the understanding and treatment of kidney diseases. With an ISSN of 1319-2442 and E-ISSN 2320-3838, this esteemed peer-reviewed journal aims to facilitate scholarly exchange and promote innovative research since its inception in 2006. Recognized for its Open Access model since 2007, it enables widespread dissemination of critical findings, thereby enhancing the global impact of kidney-related research. With a solid reputation reflected in its current Q3 categorization in both Nephrology and Transplantation for 2023, the journal continues to contribute meaningfully to these essential medical fields. Researchers, clinical professionals, and students can access its wealth of information to further their knowledge and practice in kidney health and organ transplantation, vital components in the landscape of modern medicine.

Canadian Journal of Kidney Health and Disease, published by SAGE Publications Inc, is a leading open-access journal dedicated to advancing the field of nephrology. Established in 2014, the journal aims to bridge the gap between research and clinical practice by disseminating high-quality clinical and experimental research findings, reviews, and case studies that focus on kidney health and associated disorders. With an impressive impact factor and ranked in the Q2 category for nephrology, the journal fosters an environment for interdisciplinary collaboration and innovation, enhancing the visibility of crucial advancements in kidney disease research. As an open-access journal, it ensures that valuable knowledge is accessible to researchers, healthcare professionals, and students globally, facilitating a deeper understanding of kidney health issues and promoting improved patient care. Located in the United Kingdom, the journal continues to expand its reach and influence within the nephrology community, leveraging its open-access model to encourage a diverse audience in exploring cutting-edge findings and sharing insights pertinent to kidney health.

Renal Replacement Therapy is an esteemed open-access journal published by BMC, dedicated to advancing the field of nephrology, transplantation, and urology. Established in 2015, the journal aims to disseminate high-quality research findings to enhance the understanding and management of kidney-related diseases and therapies. Renal Replacement Therapy is ranked in the third quartile (Q3) in the categories of Nephrology, Transplantation, and Urology as of 2023, reflecting its growing influence and commitment to academic excellence. The journal encourages interdisciplinary study and collaboration, welcoming contributions from researchers, clinicians, and healthcare professionals. With a focus on practical applications and innovative therapies, this journal is instrumental for those seeking the latest insights and advancements in renal replacement strategies. Located in the United Kingdom, the journal strives to provide unparalleled access to critical research, ensuring that its findings are available to a global audience striving to improve patient outcomes in renal health.

Kidney Medicine is a pioneering Open Access journal dedicated to advancing the field of nephrology and internal medicine, published by Elsevier. Since its inception in 2019, it has rapidly established itself as a vital resource, currently ranked in the Q2 category for Internal Medicine and Q1 for Nephrology by 2023, reflecting its influence and critical contributions to both disciplines. With an impressive Scopus ranking, positioning it at #24 out of 81 in Nephrology, the journal serves as an essential platform for researchers, clinicians, and students eager to disseminate and access high-quality research. By providing open access to a diverse array of articles, Kidney Medicine ensures that vital research reaches a wide audience, thereby facilitating knowledge exchange and innovation within the community. Its ongoing commitment to excellence and relevance makes it a key player in shaping the future of kidney health worldwide.

Revista de Nefrologia Dialisis y Trasplante (ISSN: 0326-3428; E-ISSN: 2346-8548) is a prominent open-access journal published by the ASOC REGIONAL DIALISIS TRASPLANTES RENALES since 2013, located in Buenos Aires, Argentina. This journal serves as a vital platform for the dissemination of pivotal research findings in the fields of nephrology and transplantation, covering a wide range of topics including clinical practices, patient outcomes, and innovative therapies. Although currently ranked in the Q4 category in both Nephrology and Transplantation by Scopus, the journal aims to elevate the discourse within these scientific communities by providing accessible and high-quality research to professionals and researchers alike. With its commitment to advancing knowledge and fostering collaboration among scientists, practitioners, and students, the Revista de Nefrologia Dialisis y Trasplante plays an essential role in addressing the critical challenges and developments in kidney health and organ transplantation.

Kidney International Reports, published by ELSEVIER SCIENCE INC, stands as a premier open-access journal in the realm of nephrology, having established itself since its inception in 2016. This scholarly platform, with an ISSN of 2468-0249, is dedicated to presenting high-quality research and critical reviews that advance our understanding of kidney health and disease. With a remarkable Q1 ranking in nephrology and a notable position within the top 10 of Scopus rankings for this specialty, the journal is a pivotal resource for researchers, healthcare professionals, and students alike. Featuring a broad scope of topics from clinical nephrology to innovative treatment strategies, Kidney International Reports ensures accessibility to the latest findings through its open access model, making it instrumental in promoting knowledge sharing and collaboration across the global nephrology community. The journal's commitment to excellence not only enhances the visibility of research but also fosters the development of effective treatments and therapies for kidney diseases.

The International Journal of Nephrology and Renovascular Disease is a prestigious peer-reviewed journal dedicated to advancing the field of nephrology and related renal research. Published by DOVE MEDICAL PRESS LTD, this open access journal has been a vital resource for the nephrology community since its inception in 2008. With a focus on innovative studies and emerging trends, the journal has established itself in the scholarly landscape, achieving an impressive Q2 ranking within the nephrology category according to the 2023 Scopus metrics, and positioning itself at rank #33 out of 81 journals in the field. The journal aims to provide a platform for both established researchers and emerging scholars to share their findings and insights, significantly contributing to improving patient outcomes and enhancing the understanding of renal health. As it continuously seeks to publish high-quality research that reflects the latest developments in the discipline, the International Journal of Nephrology and Renovascular Disease serves as an indispensable tool for anyone involved in nephrology research, clinical practice, and education.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.